---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-26-001534"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2026-02-20T23:59:59+00:00"
generated_at: "2026-05-16T01:26:31.577064+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# KALA Bio director David Lazar resigns from board effective February 16, 2026

## Summary
- David Lazar resigned as a member of the Board of Directors of KALA Bio on February 16, 2026.
- Resignation was effective immediately and not due to any disagreement with the company.
- No replacement for Lazar's board seat has been announced in this filing.
- The company filed the 8-K on February 20, 2026, reflecting the departure.

## SEC filing metadata
- accession: 0001829126-26-001534
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2026-02-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000182912626001534/0001829126-26-001534-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000182912626001534/kalabio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-26-001534
- JSON: https://secwatch.observer/filing/0001829126-26-001534.json
- Plain text: https://secwatch.observer/filing/0001829126-26-001534.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.